| Anthem (NASDAQ:ANTX) is now covered by Guggenheim. They set a "buy" rating and a $9.00 price target on the stock. This represents a 87.5% upside from the current price of $4.80. |
| BP (NYSE:BP) is now covered by Mizuho. They set an "outperform" rating and a $51.00 price target on the stock. This represents a 21.3% upside from the current price of $42.04. |
| Brainsway (NASDAQ:BWAY) is now covered by BTIG Research. They set a "buy" rating and a $18.00 price target on the stock. This represents a 9.1% upside from the current price of $16.50. |
| DPC (NYSE:DPC) is now covered by Royal Bank Of Canada. They set an "outperform" rating and a $53.00 price target on the stock. This represents a 16.7% upside from the current price of $45.40. |
| DPC (NYSE:DPC) is now covered by Morgan Stanley. They set an "equal weight" rating and a $47.00 price target on the stock. This represents a 3.5% upside from the current price of $45.40. |
| DPC (NYSE:DPC) is now covered by Rothschild & Co Redburn. They set a "buy" rating and a $53.50 price target on the stock. This represents a 17.8% upside from the current price of $45.40. |
| DPC (NYSE:DPC) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating and a $56.00 price target on the stock. This represents a 23.4% upside from the current price of $45.40. |
| Enpro (NYSE:NPO) is now covered by JPMorgan Chase & Co.. They set an "overweight" rating and a $420.00 price target on the stock. This represents a 28.9% upside from the current price of $325.72. |
| Gloo (NASDAQ:GLOO) is now covered by Citizens Jmp. They set a "market outperform" rating and a $8.00 price target on the stock. This represents a 135.3% upside from the current price of $3.40. |
| Honeywell Aerospace (NASDAQ:HONA) is now covered by UBS Group AG. They set a "neutral" rating and a $231.00 price target on the stock. This represents a 14.1% upside from the current price of $202.47. |
| Kinetik (NYSE:KNTK) is now covered by Tudor Pickering. They set a "buy" rating and a $57.00 price target on the stock. This represents a 11.5% upside from the current price of $51.11. |
| Moog (NYSE:MOG.A) is now covered by JPMorgan Chase & Co.. They set an "overweight" rating and a $520.00 price target on the stock. This represents a 31.3% upside from the current price of $396.13. |
| Neuronetics (NASDAQ:STIM) is now covered by BTIG Research. They set a "buy" rating and a $5.00 price target on the stock. This represents a 147.5% upside from the current price of $2.02. |
| NextNav (NASDAQ:NN) is now covered by Odeon Capital Group LLC. They set a "buy" rating and a $22.00 price target on the stock. This represents a 71.3% upside from the current price of $12.84. |
| NN (NASDAQ:NNBR) is now covered by Craig Hallum. They set a "buy" rating and a $7.00 price target on the stock. This represents a 101.1% upside from the current price of $3.48. |
| Rein Therapeutics (NASDAQ:RNTX) is now covered by Maxim Group. They set a "buy" rating and a $4.00 price target on the stock. This represents a 373.9% upside from the current price of $0.84. |
| Sensei Biotherapeutics (NASDAQ:FTH) is now covered by Citizens Jmp. They set an "outperform" rating and a $51.00 price target on the stock. This represents a 80.9% upside from the current price of $28.19. |
| Shattuck Labs (NASDAQ:STTK) is now covered by Leerink Partners. They set an "outperform" rating and a $16.00 price target on the stock. This represents a 134.6% upside from the current price of $6.82. |
| Shell (NYSE:SHEL) is now covered by Mizuho. They set a "neutral" rating and a $98.00 price target on the stock. This represents a 13.7% upside from the current price of $86.20. |
| Soluna (NASDAQ:SLNH) is now covered by HC Wainwright. They set a "buy" rating and a $4.00 price target on the stock. This represents a 194.1% upside from the current price of $1.36. |
| SOPHiA GENETICS (NASDAQ:SOPH) is now covered by HC Wainwright. They set a "buy" rating and a $12.00 price target on the stock. This represents a 89.6% upside from the current price of $6.33. |
| TotalEnergies (NYSE:TTE) is now covered by Mizuho. They set an "outperform" rating and a $103.00 price target on the stock. This represents a 27.1% upside from the current price of $81.04. |
| Trulieve Cannabis (NYSE:TRLV) is now covered by Cantor Fitzgerald. They set an "overweight" rating and a $15.00 price target on the stock. This represents a 71.8% upside from the current price of $8.73. |